» Articles » PMID: 28264441

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2017 Mar 8
PMID 28264441
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Epilepsy is a neurological disorder affecting around 1%-2% of population worldwide and its treatment includes use of antiepileptic drugs to control seizures. Failure to respond to antiepileptic drug therapy is a major clinical problem and over expression of ATP-binding cassette transporters is considered one of the major reasons for pharmacoresistance. In this review, we have summarized the regulation of ABC transporters in response to oxidative stress due to disease and antiepileptic drugs. Further, ketogenic diet and antioxidants were examined for their role in pharmacoresistance. The understanding of signalling pathways and mechanism involved may help in identifying potential therapeutic targets and improving drug response.

Citing Articles

Anticonvulsant effect of glycitin in pentylenetetrazol induced male Wistar rat model by targeting oxidative stress and Nrf2/HO-1 signaling.

Hakimi Naeini S, Rajabi-Maham H, Azizi V, Hosseini A Front Pharmacol. 2024; 15:1392325.

PMID: 39246658 PMC: 11377222. DOI: 10.3389/fphar.2024.1392325.


Diet-derived circulating antioxidants and risk of epilepsy: a Mendelian randomization study.

Huang S, Chen Y, Wang Y, Pan S, Lu Y, Gao W Front Neurol. 2024; 15:1422409.

PMID: 39036635 PMC: 11258006. DOI: 10.3389/fneur.2024.1422409.


The impact of ATP-binding cassette transporters in the diseased brain: Context matters.

Baltira C, Aronica E, Elmquist W, Langer O, Loscher W, Sarkaria J Cell Rep Med. 2024; 5(6):101609.

PMID: 38897176 PMC: 11228798. DOI: 10.1016/j.xcrm.2024.101609.


Challenges and prospects in geriatric epilepsy treatment: the role of the blood-brain barrier in pharmacotherapy and drug delivery.

Chen X, Luo J, Song M, Pan L, Qu Z, Huang B Front Aging Neurosci. 2024; 16:1342366.

PMID: 38389560 PMC: 10882099. DOI: 10.3389/fnagi.2024.1342366.


Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation.

Madireddy S, Madireddy S Brain Sci. 2023; 13(5).

PMID: 37239256 PMC: 10216584. DOI: 10.3390/brainsci13050784.


References
1.
Zhang C, Zuo Z, Kwan P, Baum L . In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein. Epilepsia. 2011; 52(10):1894-904. DOI: 10.1111/j.1528-1167.2011.03140.x. View

2.
Maalouf M, Rho J, Mattson M . The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2008; 59(2):293-315. PMC: 2649682. DOI: 10.1016/j.brainresrev.2008.09.002. View

3.
Loscher W, Luna-Tortos C, Romermann K, Fedrowitz M . Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected. Curr Pharm Des. 2011; 17(26):2808-28. DOI: 10.2174/138161211797440212. View

4.
Turkdogan D, Toplan S, Karakoc Y . Lipid peroxidation and antioxidative enzyme activities in childhood epilepsy. J Child Neurol. 2002; 17(9):673-6. DOI: 10.1177/088307380201700904. View

5.
Liang L, Waldbaum S, Rowley S, Huang T, Day B, Patel M . Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin. Neurobiol Dis. 2011; 45(3):1068-76. PMC: 3418969. DOI: 10.1016/j.nbd.2011.12.025. View